PMV Pharmaceuticals
(NASDAQ) PMVP
PMV Pharmaceuticals Financials at a Glance
Market Cap
$70.93M
Revenue (TTM)
$0.00
Net Income (TTM)
$77.74M
EPS (TTM)
$-1.48
P/E Ratio
-0.90
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$1.30
Volume
12
Open
$1.30
Price
$1.30
Volume
12
Open
$1.30
Previous Close
$1.33
Daily Range
$1.30 - $1.30
52-Week Range
$0.81 - $1.88
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$1.30
Volume
12
Open
$1.30
Previous Close
$1.33
Daily Range
$1.30 - $1.30
52-Week Range
$0.81 - $1.88
PMVP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PMV Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
54
CEO
David H. Mack, PhD
Website
www.pmvpharma.comHeadquarters
Princeton, NJ 08512, US
PMVP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-55%
Return on Capital
-82%
Return on Assets
-67%
Earnings Yield
-1.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$70.93M
Shares Outstanding
53.33M
Volume
12
Short Interest
0.00%
Avg. Volume
600.19K
Financials (TTM)
Gross Profit
$133.00K
Operating Income
$86.21M
EBITDA
$86.21M
Operating Cash Flow
$73.58M
Capital Expenditure
$29.00K
Free Cash Flow
$73.61M
Cash & ST Invst.
$112.94M
Total Debt
$838.00K
PMV Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$33.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$70.93M
N/A
Market Cap/Employee
$1.51M
N/A
Employees
47
N/A
Net Income
$18.04M
+21.6%
EBITDA
$19.21M
+23.6%
Quarterly Fundamentals
Net Cash
$112.11M
-33.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$435.00K
-48.1%
Short Term Debt
$403.00K
+14.5%
Return on Assets
-66.70%
N/A
Return on Invested Capital
-81.99%
N/A
Free Cash Flow
$17.20M
-2.9%
Operating Cash Flow
$17.19M
-3.2%